[ccpw id="5"]

Home.forex news reportWorkday announces CEO change, shares drop as analysts flag questionable timing

Workday announces CEO change, shares drop as analysts flag questionable timing

-


Workday announces CEO change, shares drop as analysts flag questionable timing
Workday announces CEO change, shares drop as analysts flag questionable timing Proactive uses images sourced from Shutterstock

Workday Inc (NASDAQ:WDAY) shares fell more than 6% after the company announced that co-founder and current executive chair Aneel Bhusri will return as chief executive officer.

Carl Eschenbach, who has served as CEO for the past three years, is stepping down and leaving the board but will remain involved as a strategic advisor to Bhusri, the company said.

“It’s been a privilege to serve as CEO over the past three years and I’m proud of all we achieved — instilling greater operational discipline, expanding globally, broadening our industry focus, and laying meaningful groundwork in AI,” Eschenbach said in a statement.

Analysts at Jefferies raised concerns about the timing and implications of the leadership change, noting it comes six days after the end of fiscal Q4 for the company.

“Co-founder Aneel Bhusri taking over raises questions, given he turned the company over to Carl in 2024 as sole CEO to focus on product/AI,” they wrote. “Something isn’t right.”

They added that “many view this move as short-term with more management change ahead and question if WDAY can hit its medium-term targets,” and noted that while AI remains a focus, slowed growth and potential margin pressures could be a concern.

The Jefferies analysts noted that they are awaiting further clarity at Workday’s earnings release on February 24.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

Market Update: CNC, SHEL, VSH, PSX, PLTR

Market Update: CNC, SHEL, VSH, PSX, PLTR Source link

FDA says Novo Nordisk's TV ad for obesity pill includes 'false or misleading' claims

The Food and Drug Administration said Novo Nordisk's TV advertisement for its newly launched Wegovy pill for obesity included "false or misleading" claims about...

Analyst Report: Flex Ltd

Analyst Report: Flex Ltd Source link

Follow us

0FansLike
0FollowersFollow
0SubscribersSubscribe

Most Popular

spot_img